1. Authors
    2. /
  2. Claude Walker
    3. /

Claude Walker

Claude was an analyst and advisor at The Motley Fool.

Recent Articles

a woman
⏸️ Investing

Bentham IMF Limited positioning to profit from Forge Group Limited collapse

| Claude Walker

Bentham IMF looks attractive for long-term investors at current prices.

Read more »

a woman
⏸️ Investing

My top 3 speculative stocks for 2014 revisited

| Claude Walker

The risks and rewards of speculative investments can be quite a distraction from the search for a great business at…

Read more »

a woman
⏸️ Investing

CSL Limited results presentation: Hizentra, Kcentra and buying back shares

| Claude Walker

Do you know the difference between Hizentra and Kcentra?

Read more »

a woman
⏸️ Investing

My 3 most embarrassing investing mistakes of 2013

| Claude Walker

It's a lot harder to write about your mistakes than your successes, I've learnt that much already!

Read more »

a woman
⏸️ Investing

Fairfax missing the point on the failed Forge Group Limited

| Claude Walker

Anyone can see that Forge Group did not display adequate respect for shareholders.

Read more »

a woman
⏸️ Investing

7 solid stocks yielding over 7%

| Claude Walker

These 7 companies will pay you more than twice as much as a term deposit; but which are the best…

Read more »

a woman
⏸️ Investing

Superstar stock: CSL Limited

| Claude Walker

This famous biotech has seen almost unparalleled growth, especially in the last decade.

Read more »

⏸️ Investing

Telco watch: Will Turnbull block TPG's fibre plans and could iiNet Limited team up with Vodafone?

| Claude Walker

The Australian telecommunications industry is constantly changing. How does it impact your portfolio?

Read more »

a woman
⏸️ Investing

CSL Limited results rundown: first half of FY 2014 was solid, not spectacular

| Claude Walker

Low growth might disappoint the market: should you buy, sell or hold?

Read more »

a woman
⏸️ Investing

David Jones Limited chairman and directors finally resign

| Claude Walker

Could a refreshed board pay greater respect to shareholders, or even retain the outgoing CEO, Paul Zahra?

Read more »

a woman
⏸️ Investing

Admedus wins US Food and Drug Administration approval to sell CardioCel in the USA

| Claude Walker

Is Fortescue founder Andrew Forrest onto another winner?

Read more »

⏸️ Investing

Will you become a victim of changing energy trends?

| Claude Walker

Note the words of the President of the World Bank and avoid future losses.

Read more »

a woman
⏸️ Investing

3 discounted growth stocks you could buy today

| Claude Walker

Don’t be a victim of market sentiment; take the opportunity to profit!

Read more »

a woman
⏸️ Investing

3 safe stocks to buy at good prices

| Claude Walker

Don't miss an opportunity to buy a share of these 3 excellent businesses at a discount price.

Read more »

a woman
⏸️ Investing

A stock picker's guide to REA Group Limited in 2014

| Claude Walker

Is REA Group Limited the best business on the ASX?

Read more »

⏸️ Investing

Exposure to foreign markets makes ANZ riskier than the Commonwealth Bank of Australia

| Claude Walker

Which bank shares are the safest?

Read more »

a woman
⏸️ Investing

Are new coal mines a path to wealth?

| Claude Walker

Is it wise to bet on growing demand for coal?

Read more »

a woman
⏸️ Investing

6 top rollup companies for your watchlist

| Claude Walker

Smart acquisitions make these ASX companies profitable investments.

Read more »

a woman
⏸️ Investing

The stock picker's guide to Sonic Healthcare Limited in 2014

| Claude Walker

Buy, sell or hold? What you need to know about Sonic Healthcare Limited in 2014.

Read more »

⏸️ Investing

3 high-conviction stocks and why you should own them

| Claude Walker

What stocks would you hold, even during a market panic?

Read more »

a woman
⏸️ Investing

ResMed Inc's results release makes today a good day to buy

| Claude Walker

ResMed’s share price is down despite solid results and bright prospects.

Read more »

a woman
⏸️ Investing

Insurance Australia Group Limited upgrades FY 2014 guidance

| Claude Walker

Is now the time to buy Insurance Australia Group?

Read more »

a woman
⏸️ Investing

Is this one sector you should avoid?

| Claude Walker

Investing in coal companies is insufficiently profitable to justify the risk.

Read more »

a woman
⏸️ Investing

Is now the time to buy SEEK Limited?

| Claude Walker

Will planned asset sales provide a big payday for Seek shareholders?

Read more »

a woman
⏸️ Investing

Telstra to battle iiNet Limited and Vocus Communications Limited in court

| Claude Walker

Telstra is suing the ACCC, Vocus and iiNet because it wants to charge the smaller telcos more for access to…

Read more »

a woman
⏸️ Investing

Is your portfolio ready for a slowing Chinese economy?

| Claude Walker

George Soros has warned that China’s growth model is unsustainable.

Read more »

a woman
⏸️ Investing

These 5 healthcare stocks will secure you a healthy financial future

| Claude Walker

Demographic changes, an ageing population and the end of the mining boom mean that all long-term stock market investors should…

Read more »

a woman
⏸️ Investing

Morgan Stanley says divestment campaigns are gaining traction in 2014

| Claude Walker

How can divestment campaigns hurt your portfolio?

Read more »

⏸️ Investing

Telstra Corporation Ltd, Vodafone and Optus: buy, sell or hold?

| Claude Walker

Are you planning to profit from the mobile data boom?

Read more »

a woman
⏸️ Investing

Is this your opportunity to buy Wotif.com or Webjet Limited at an attractive price?

| Claude Walker

Increasing competition is putting pressure on Australia’s dominant travel booking companies, but is this creating an opportunity for investors?

Read more »

a woman
⏸️ Investing

Should you buy Insurance Australia Group Limited?

| Claude Walker

How can the teachings of Warren Buffett help us analyse insurance companies?

Read more »

⏸️ Investing

The 10 most shorted stocks on the ASX

| Claude Walker

Is this your big opportunity to profit from short sellers who are betting against Cochlear?

Read more »

a woman
⏸️ Investing

Should you avoid IT companies, or is now the time to buy?

| Claude Walker

Data#3 and UXC have recently provided pessimistic guidance: is this just the beginning of a slump?

Read more »

a woman
⏸️ Investing

7 ways to play the ageing population

| Claude Walker

Owners of these 7 stocks will prosper as the average age of the Australian population increases.

Read more »

a woman
⏸️ Investing

3 top telcos that continue to grow by acquisition

| Claude Walker

Investors in Australia’s best telecommunication companies will continue to make impressive capital gains on top of receiving regular dividends.

Read more »

⏸️ Investing

Should you buy more Insurance Australia Group shares?

| Claude Walker

Existing IAG shareholders can currently apply for shares at $5.47.

Read more »

a woman
⏸️ Investing

3 small-cap stocks for smart money in 2014

| Claude Walker

How do the words of Charlie Munger apply to these three underrated investments?

Read more »

⏸️ Investing

Will Telstra continue to dominate in 2014?

| Claude Walker

Telstra looks to be winning the competition for mobile customers.

Read more »

a woman
⏸️ Investing

3 medical micro-caps with global ambitions

| Claude Walker

Resonance Health soared 200% in a single day: Is there still an opportunity?

Read more »

a woman
⏸️ Investing

Will you profit from the emerging pathology services duopoly?

| Claude Walker

Sonic Healthcare and Primary Healthcare are consolidating the industry, with smaller players suffering from excessive rents.

Read more »